An assessment of the vaccination of school-aged children in England against SARS-CoV-2.
Matt J KeelingSam E MoorePublished in: BMC medicine (2022)
Vaccination of 12-170-year-olds and 5-11-year-olds is projected to generate a reduction in infection, hospital admission and deaths for both the age groups involved and the population in general. For any decision involving childhood vaccination, these benefits needs to be balanced against potential adverse events from the vaccine, the operational constraints on delivery and the potential for diverting resources from other public health campaigns.